COSCIENS Biopharma Inc. CSCI
2.72 USD 0.00 (+0.00%)
At closeJul 7, 2026, 4:00 PM EDT
2.72 Day range 2.72
2.50 52-week range 11.10
- YTD
- +33.99%
- 1 year
- +33.99%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 9.59M | 7.14M | 14.57M | 5.26M | 3.65M | |
| 4.73M | 2.94M | 8.56M | 5.17M | 1.33M | |
| -18.28M | -4.63M | 4.32M | -8.67M | -5.71M | |
| -15.31M | -3.48M | 3.45M | -8.37M | -5.12M | |
| -5.93 | -1.89 | 1.86 | -7.28 | -12.44 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 16.39M | 6.68M | 50.61M | 65.30M | 24.61M | |
| 35.07M | 23.75M | 56.03M | 80.10M | 37.01M | |
| 21.91M | 2.71M | 20.25M | 27.12M | 23.79M | |
| 2.31M | 1.70M | 179.00K | 161.00K | 184.00K | |
| 13.16M | 21.04M | 35.78M | 52.99M | 13.21M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -14.57M | -2.58M | 5.23M | -8.58M | -4.13M | |
| 25.08M | -730.00K | -304.00K | -658.00K | 56.00K | |
| -588.00K | -357.00K | -267.00K | 51.04M | 20.47M | |
| -1.16M | -722.00K | -304.00K | -29.00K | 6.00K | |
| 9.71M | -3.51M | 4.03M | 41.03M | 16.43M |